670
Participants
Start Date
January 31, 2014
Primary Completion Date
March 31, 2015
Study Completion Date
April 30, 2015
Active Comparator EBI-005
Placebo Comparator
Investigational Site, New York
Investigational Site, Wantagh
Investigational Site, Rochester
Investigational Site, Pittsburgh
Investigational Site, Cranberry Township
Investigational Site, Lancaster
Investigational Site, Norfolk
Investigational Site, High Point
Investigational Site, Roswell
Investigational Site, Plantation
Investigational Site, Memphis
Investigational Site, Louisville
Investigational Site, Louisville
Investigational Site, Lexington
Investigational Site, Cleveland
Investigational Site, Indianapolis
Investigational Site, Indianapolis
Investigational Site, New Albany
Investigational Site, Rapid City
Investigational Site, Bloomingdale
Investigational Site, Chesterfield
Investigational Site, Washington
Investigational Site, Des Peres
Investigational Site, St Louis
Investigational Site, Kansas City
Investigational Site, Little Rock
Investigational Site, Houston
Investigational Site#2, Houston
Investigational Site, League City
Investigational Site, San Antonio
Investigational Site# 2, San Antonio
Investigational Site, Littleton
Investigational Site, Mesa
Investigational Site, Chandler
Investigational Site, Las Vegas
Investigational Site, Torrence
Investigational Site, Artesia
Investigational Site, Mission Hills
Investiational Site, San Diego
Investigational Site, Petaluma
Investigational Site, Rancho Cordova
Investigational Site, Hamden
Investigational Site, Bangor
Investigational Site, Boston
Investigational Site, Winchester
Lead Sponsor
Eleven Biotherapeutics
INDUSTRY